Login
Home
Charts
Search
Watchlist
Products

Diamines & Chemicals Ltd

DIAMINESQ·NSE
249.38-2.15%Wed, 23 Sept '26

Diamines & Chemicals Ltd

DIAMINESQ
NSE
249.38
-2.15%
|Wed, 23 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
251Cr
Close
Close Price
249.38
Industry
Industry
Chemicals - Speciality
PE
Price To Earnings
PS
Price To Sales
6.18
Revenue
Revenue
41Cr
Rev Gr TTM
Revenue Growth TTM
-39.29%
PAT Gr TTM
PAT Growth TTM
-615.71%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
202329171918181298914
Growth YoY
Revenue Growth YoY%
-26.2-7.4-17.7-46.9-3.7-24.0-39.0-27.3-51.5-56.4-48.217.3
Expenses
ExpensesCr
151826181616161613101214
Operating Profit
Operating ProfitCr
553-1422-4-4-3-30
OPM
OPM%
25.120.511.5-8.118.88.69.4-32.2-41.8-37.3-33.52.6
Other Income
Other IncomeCr
111111121111
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
543-2312-3-4-3-30
Tax
TaxCr
1110100000-10
PAT
PATCr
432-2311-3-4-3-20
Growth YoY
PAT Growth YoY%
-69.8-67.0-77.0-124.3-32.4-72.5-40.0-61.2-261.5-509.9-282.698.2
NPM
NPM%
18.712.87.5-10.113.14.67.4-22.4-43.8-43.5-25.9-0.3
EPS
EPS
3.83.02.3-1.72.60.81.3-2.9-4.2-3.5-2.4-0.1
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
202329171918181298914
Growth YoY
Revenue Growth YoY%
-26.2-7.4-17.7-46.9-3.7-24.0-39.0-27.3-51.5-56.4-48.217.3
Expenses
ExpensesCr
151826181616161613101214
Operating Profit
Operating ProfitCr
553-1422-4-4-3-30
OPM
OPM%
25.120.511.5-8.118.88.69.4-32.2-41.8-37.3-33.52.6
Other Income
Other IncomeCr
111111121111
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
111111111111
PBT
PBTCr
543-2312-3-4-3-30
Tax
TaxCr
1110100000-10
PAT
PATCr
432-2311-3-4-3-20
Growth YoY
PAT Growth YoY%
-69.8-67.0-77.0-124.3-32.4-72.5-40.0-61.2-261.5-509.9-282.698.2
NPM
NPM%
18.712.87.5-10.113.14.67.4-22.4-43.8-43.5-25.9-0.3
EPS
EPS
3.83.02.3-1.72.60.81.3-2.9-4.2-3.5-2.4-0.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
67574439366366111104713841
Growth
Revenue Growth%
-14.2-23.5-11.0-9.05.267.2-5.9-31.3-46.2-39.3
Expenses
ExpensesCr
575038343138445581665250
Operating Profit
Operating ProfitCr
108654252256235-14-9
OPM
OPM%
15.413.513.212.612.540.033.350.221.87.6-35.9-23.3
Other Income
Other IncomeCr
000003233343
Interest Expense
Interest ExpenseCr
443330000000
Depreciation
DepreciationCr
222222223344
PBT
PBTCr
52000262256225-14-11
Tax
TaxCr
10010551462-1-1
PAT
PATCr
410-20211742163-13-10
Growth
PAT Growth%
-61.7-71.2-510.0115.6-20.4150.7-62.1-81.4-524.8-615.7
NPM
NPM%
5.32.40.9-4.10.733.425.337.915.34.1-32.6-24.3
EPS
EPS
3.61.40.4-1.60.321.517.142.816.22.8-13.1-10.2
Financial YearMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
67574439366366111104713841
Growth
Revenue Growth%
-14.2-23.5-11.0-9.05.267.2-5.9-31.3-46.2-39.3
Expenses
ExpensesCr
575038343138445581665250
Operating Profit
Operating ProfitCr
108654252256235-14-9
OPM
OPM%
15.413.513.212.612.540.033.350.221.87.6-35.9-23.3
Other Income
Other IncomeCr
000003233343
Interest Expense
Interest ExpenseCr
443330000000
Depreciation
DepreciationCr
222222223344
PBT
PBTCr
52000262256225-14-11
Tax
TaxCr
10010551462-1-1
PAT
PATCr
410-20211742163-13-10
Growth
PAT Growth%
-61.7-71.2-510.0115.6-20.4150.7-62.1-81.4-524.8-615.7
NPM
NPM%
5.32.40.9-4.10.733.425.337.915.34.1-32.6-24.3
EPS
EPS
3.61.40.4-1.60.321.517.142.816.22.8-13.1-10.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1010101010101010101010
Reserves
ReservesCr
24242523237590125138139147
Current Liabilities
Current LiabilitiesCr
33262118166613101214
Non Current Liabilities
Non Current LiabilitiesCr
979128444453
Total Liabilities
Total LiabilitiesCr
756665635795111151163178174
Current Assets
Current AssetsCr
3426242219565469759073
Non Current Assets
Non Current AssetsCr
40414140383957828888102
Total Assets
Total AssetsCr
756665635795111151163178174
Financial YearMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1010101010101010101010
Reserves
ReservesCr
24242523237590125138139147
Current Liabilities
Current LiabilitiesCr
33262118166613101214
Non Current Liabilities
Non Current LiabilitiesCr
979128444453
Total Liabilities
Total LiabilitiesCr
756665635795111151163178174
Current Assets
Current AssetsCr
3426242219565469759073
Non Current Assets
Non Current AssetsCr
40414140383957828888102
Total Assets
Total AssetsCr
756665635795111151163178174

Cash Flow

Consolidated
Standalone
Financial YearMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
221632715271622-5-11
Investing Cash Flow
Investing Cash FlowCr
-4-5110-15-21-9-1915-29
Financing Cash Flow
Financing Cash FlowCr
-13-11-4-3-7-4-5-6-31018
Net Cash Flow
Net Cash FlowCr
50000-312019-22
Free Cash Flow
Free Cash FlowCr
1711227415-713-9-32
CFO To PAT
CFO To PAT%
623.91,187.9701.1-156.42,866.673.2163.238.9137.8-170.086.5
CFO To EBITDA
CFO To EBITDA%
213.0206.246.950.7159.761.2123.829.396.5-92.478.6
Financial YearMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
221632715271622-5-11
Investing Cash Flow
Investing Cash FlowCr
-4-5110-15-21-9-1915-29
Financing Cash Flow
Financing Cash FlowCr
-13-11-4-3-7-4-5-6-31018
Net Cash Flow
Net Cash FlowCr
50000-312019-22
Free Cash Flow
Free Cash FlowCr
1711227415-713-9-32
CFO To PAT
CFO To PAT%
623.91,187.9701.1-156.42,866.673.2163.238.9137.8-170.086.5
CFO To EBITDA
CFO To EBITDA%
213.0206.246.950.7159.761.2123.829.396.5-92.478.6

Ratios

Consolidated
Standalone
Financial YearMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4024202733258266393492307234251
Price To Earnings
Price To Earnings
11.819.152.4134.612.315.99.431.8112.4
Price To Sales
Price To Sales
0.60.40.50.70.94.14.03.54.74.36.16.2
Price To Book
Price To Book
1.30.80.70.91.13.02.62.93.32.11.51.6
EV To EBITDA
EV To EBITDA
5.95.16.38.810.09.010.26.620.048.8-15.2-24.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.425.329.028.729.359.953.565.642.334.519.819.8
OPM
OPM%
15.413.513.212.612.540.033.350.221.87.6-35.9-23.3
NPM
NPM%
5.32.40.9-4.10.733.425.337.915.34.1-32.6-24.3
ROCE
ROCE%
15.110.87.26.26.330.322.142.015.13.4-8.3-8.3
ROE
ROE%
10.64.01.1-4.90.824.716.731.210.72.0-8.0-8.0
ROA
ROA%
4.72.00.6-2.50.422.115.127.79.81.7-7.2-7.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
4024202733258266393492307234251
Price To Earnings
Price To Earnings
11.819.152.4134.612.315.99.431.8112.4
Price To Sales
Price To Sales
0.60.40.50.70.94.14.03.54.74.36.16.2
Price To Book
Price To Book
1.30.80.70.91.13.02.62.93.32.11.51.6
EV To EBITDA
EV To EBITDA
5.95.16.38.810.09.010.26.620.048.8-15.2-24.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
26.425.329.028.729.359.953.565.642.334.519.819.8
OPM
OPM%
15.413.513.212.612.540.033.350.221.87.6-35.9-23.3
NPM
NPM%
5.32.40.9-4.10.733.425.337.915.34.1-32.6-24.3
ROCE
ROCE%
15.110.87.26.26.330.322.142.015.13.4-8.3-8.3
ROE
ROE%
10.64.01.1-4.90.824.716.731.210.72.0-8.0-8.0
ROA
ROA%
4.72.00.6-2.50.422.115.127.79.81.7-7.2-7.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Diamines & Chemicals Ltd (DACL) is fundamentally a maker of ethylene amines - the chemical building blocks that go into medicines, crop-protection sprays, water-treatment formulas and oilfield additives - and it has held that ground for nearly five decades from a single plant inside the Vadodara petrochemicals complex. Incorporated in 1976, the company grew by sticking to a recurring approach: develop its own process technology in-house, target products India imports, and do it with smaller, cheaper, cleaner plants - then use the cash that approach generates to seed a second manufacturing site and a joint venture. Everything the business does flows from that same R&D-first, import-substitution logic. # Business segments Two engines at different stages - a specialty-chemicals cash generator built on decades of in-house process know-how, and a trading division that repurposes the company’s existing commercial setup - with a subsidiary platform and a joint venture still in their build-out phase. ## 1. Ethylene amines and specialty chemicals: the molecule factory that carries the company **DACL makes a family of nitrogen-based intermediates that downstream manufacturers cannot do without, and it competes against larger global players by being the reliable, technically responsive local supplier.** - **The product is a chemical building block, not an end-good** - ethylene amines and their derivatives are intermediates that pharmaceutical, agrochemical, resin, water-treatment and petroleum customers use to synthesise their own finished products, so demand is tied to those industries’ production rather than to consumer spending cycles. - **In-house R&D is the real production line** - the company spends roughly 2-3% of turnover on R&D, runs its own pilot plant, and has never absorbed imported technology; its stated priority is developing import-substitute products with smaller footprints and lower capital costs, which is how it stays relevant against rivals who are forward- or backward-integrated at much larger scale. - **The plant runs on a mix of grid power, captive wind and conventional fuels** - the Vadodara site consumes purchased electricity, coal and liquid fuels, supplemented by 0.75 MW of captive wind turbines in Kutch, Gujarat, which the company retains for own use after selling two older Maharashtra windmills effective January 1, 2021 because they could not offset Gujarat consumption. - **Sales are direct to industrial buyers, with exports as a pressure valve** - revenue is recognised at the point of shipment, and the company exports on an FOB basis including to SEZ units and against advance authorisations, though foreign-exchange outgo on imported raw materials typically exceeds export earnings, reflecting India’s net-import position in the ethylene amines chain. - **A multi-year regulatory clearance effort has unlocked new capacity at the same site** - between 2022 and early 2026, DACL secured environmental clearance, a PESO petroleum-storage licence, a consolidated GPCB consent and finally a product-mix amendment that permits manufacturing of new items, described as the final permission needed to raise total production capacity at Vadodara. ## 2. Trading in fruits and vegetables: a commercial sideline on the same rails **DACL buys and sells fresh produce, using the relationships and logistics setup it already has - a margin-seeking extension, not a pivot.** - **Launched to sweat existing assets** - the trading division was started in FY23 with the explicit rationale of leveraging the company’s business expertise and customer relationships to generate better margins, and it is reported as a separate primary segment alongside specialty chemicals. - **Light on disclosed detail** - the annual reports confirm the segment exists and is material enough to be reported separately, but they disclose no revenue split, no procurement sources and no customer profile for the trading book. # Group structure and partners **DACL is the listed holding company with one wholly owned manufacturing subsidiary that has just begun production, a 35% stake in a joint venture that is yet to start, and a portfolio of listed-chemical-company shares held for surplus income.** - **DACL Fine Chem Limited is the subsidiary built for a second manufacturing footprint** - incorporated in July 2020 and capitalised partly by transferring a 54,458 sq.m industrial plot at Dahej won in an e-auction, DFCL started commercial production of specialty chemicals on 1 March 2024, with planned products including formulation chemicals and lithium-based derivatives. - **A third site is already in the pipeline** - in June 2026, DACL Fine Chem Limited signed a binding term sheet to buy roughly 50 acres of freehold industrial land at Kakinada, Andhra Pradesh, for a new chemical plant, with the agreement valid until mid-2027. - **KLJ Organic Diamines Limited is the joint venture that has not yet fired** - incorporated in December 2021 with DACL holding 35% and KLJ Organic Limited holding 65%, KODL had not commenced commercial activity as of the latest filings, and DACL has extended an 8% interest-bearing loan to it for business-purchase purposes. - **A portfolio of listed chemical stocks sits on the balance sheet** - the company holds strategic equity investments in names including Deepak Nitrite, Gujarat Fluorochemicals, PI Industries, UPL and Reliance Industries, described as a source of additional surplus income rather than an operating business. - **Promoters hold a stable majority and an ESOP scheme covers the entity** - the promoter group holds roughly 54-55% of the listed company, and the DACL-ESOP Scheme 2021 has been approved for 2,00,000 options covering employees of DACL, with grants made in multiple tranches.

Documents — Diamines & Chemicals Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/f8bhiamjg8te4izd6gokc8ou.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/phiaj8ieg6uh76loculetu5l.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/mur52tltna0875sq6ejsvbus.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/s4j0oxhjrwq5psnrlcv5g5vu.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/kd6xmn8q44gh7z5lmjqx51pm.pdf
  • Q1 FY2025 Quarterly Result (Jun 2024, PDF): https://www.stockscans.in/document/yhvsmvcpe3aq5fvj4g90gf2v.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/l7reu31ztpnx9e38vwy5cld8.pdf
  • Q1 FY2024 Quarterly Result (Jun 2023, PDF): https://www.stockscans.in/document/r0zbblq6cib7gu1qfmp71r9k.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/mg7t6ys8rg5fmapp3btc9gco.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/j6l2o32r8r48v0j513jdzyr1.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/60wdd2mcduursxdy05p1f91m.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/tewaarlu79bbv0536cuzsmvy.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/j4twsb42u23u5d37rxszloca.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/l5cktyskt8qt8vgg8g2n7kn6.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/8btq0cbt1cjhr79swcz4lnel.pdf